Suppr超能文献

人类 SULT1E1 多态性对 SULT1E1 同工酶对 17β-雌二醇、4-羟基他莫昔芬和己烯雌酚硫酸化的影响。

Impact of Human SULT1E1 Polymorphisms on the Sulfation of 17β-Estradiol, 4-Hydroxytamoxifen, and Diethylstilbestrol by SULT1E1 Allozymes.

机构信息

Department of Pharmacology, College of Pharmacy and Pharmaceutical Sciences, University of Toledo Health Science Campus, 3000 Arlington Avenue, Toledo, OH, 43614, USA.

Department of Pharmacology, College of Pharmacy, University of Kufa, Najaf, Iraq.

出版信息

Eur J Drug Metab Pharmacokinet. 2021 Jan;46(1):105-118. doi: 10.1007/s13318-020-00653-1.

Abstract

BACKGROUND AND OBJECTIVES

Previous studies have revealed that sulfation, as mediated by the estrogen-sulfating cytosolic sulfotransferase (SULT) SULT1E1, is involved in the metabolism of 17β-estradiol (E2), 4-hydroxytamoxifen (4OH-tamoxifen), and diethylstilbestrol in humans. It is an interesting question whether the genetic polymorphisms of SULT1E1, the gene that encodes the SULT1E1 enzyme, may impact on the metabolism of E2 and these two drug compounds through sulfation.

METHODS

In this study, five missense coding single nucleotide polymorphisms of the SULT1E1 gene were selected to investigate the sulfating activity of the coded SULT1E1 allozymes toward E2, 4OH-tamoxifen, and diethylstilbestrol. Corresponding cDNAs were generated by site-directed mutagenesis, and recombinant SULT1E1 allozymes were bacterially expressed, affinity-purified, and characterized using enzymatic assays.

RESULTS

Purified SULT1E1 allozymes were shown to display differential sulfating activities toward E2, 4OH-tamoxifen, and diethylstilbestrol. Kinetic analysis revealed further distinct K (reflecting substrate affinity) and V (reflecting catalytic activity) values of the five SULT1E1 allozymes with E2, 4OH-tamoxifen, and diethylstilbestrol as substrates.

CONCLUSIONS

Taken together, these findings highlighted the significant differences in E2-, as well as the drug-sulfating activities of SULT1E1 allozymes, which may have implications in the differential metabolism of E2, 4OH-tamoxifen, and diethylstilbestrol in individuals with different SULT1E1 genotypes.

摘要

背景和目的

先前的研究表明,雌激素介导的胞质磺基转移酶(SULT)SULT1E1 介导的磺化作用参与了人 17β-雌二醇(E2)、4-羟基他莫昔芬(4OH-他莫昔芬)和己烯雌酚的代谢。有趣的是,SULT1E1 基因(编码 SULT1E1 酶的基因)的遗传多态性是否会通过磺化作用影响 E2 和这两种药物化合物的代谢。

方法

在这项研究中,选择了 SULT1E1 基因的 5 个错义编码单核苷酸多态性,以研究编码 SULT1E1 同工酶对 E2、4OH-他莫昔芬和己烯雌酚的磺化活性。通过定点诱变生成相应的 cDNA,并通过酶促测定法对细菌表达、亲和纯化和表征的重组 SULT1E1 同工酶进行了研究。

结果

显示纯化的 SULT1E1 同工酶对 E2、4OH-他莫昔芬和己烯雌酚表现出不同的磺化活性。动力学分析进一步揭示了 5 种 SULT1E1 同工酶对 E2、4OH-他莫昔芬和己烯雌酚的不同 K(反映底物亲和力)和 V(反映催化活性)值。

结论

总之,这些发现强调了 SULT1E1 同工酶对 E2 以及药物磺化活性的显著差异,这可能对个体中 E2、4OH-他莫昔芬和己烯雌酚的代谢差异产生影响。不同的 SULT1E1 基因型。

相似文献

2
Human estrogen sulfotransferase (SULT1E1) pharmacogenomics: gene resequencing and functional genomics.
Br J Pharmacol. 2003 Aug;139(8):1373-82. doi: 10.1038/sj.bjp.0705369.
3
Effects of Human Sulfotransferase 2A1 Genetic Polymorphisms 3 on the Sulfation of Tibolone.
Eur J Drug Metab Pharmacokinet. 2018 Aug;43(4):415-421. doi: 10.1007/s13318-017-0458-2.
6
Effects of genetic polymorphisms on the sulfation of doxorubicin by human SULT1C4 allozymes.
J Biochem. 2021 Oct 12;170(3):419-426. doi: 10.1093/jb/mvab055.
7
Sulfation of raloxifene and 4-hydroxytamoxifen by human cytosolic sulfotransferases.
Drug Metab Dispos. 2006 Mar;34(3):361-8. doi: 10.1124/dmd.105.006551. Epub 2005 Dec 28.
8
Variable sulfation of dietary polyphenols by recombinant human sulfotransferase (SULT) 1A1 genetic variants and SULT1E1.
Drug Metab Dispos. 2007 May;35(5):740-6. doi: 10.1124/dmd.106.013987. Epub 2007 Feb 9.
10
Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.
Steroids. 2009 Jan;74(1):20-9. doi: 10.1016/j.steroids.2008.09.002. Epub 2008 Sep 11.

引用本文的文献

2
Estrogen sulfotransferase and sulfatase in steroid homeostasis, metabolic disease, and cancer.
Steroids. 2024 Jan;201:109335. doi: 10.1016/j.steroids.2023.109335. Epub 2023 Nov 10.
3
SULT genetic polymorphisms: physiological, pharmacological and clinical implications.
Expert Opin Drug Metab Toxicol. 2021 Jul;17(7):767-784. doi: 10.1080/17425255.2021.1940952. Epub 2021 Jun 30.

本文引用的文献

5
Sulfation of ritodrine by the human cytosolic sulfotransferases (SULTs): Effects of SULT1A3 genetic polymorphism.
Eur J Pharmacol. 2015 Aug 15;761:125-9. doi: 10.1016/j.ejphar.2015.04.039. Epub 2015 May 2.
6
Effects of Pharmacogenetics on the Pharmacokinetics and Pharmacodynamics of Tamoxifen.
Clin Pharmacokinet. 2015 Aug;54(8):797-810. doi: 10.1007/s40262-015-0273-3.
7
Structural plasticity in the human cytosolic sulfotransferase dimer and its role in substrate selectivity and catalysis.
Drug Metab Pharmacokinet. 2015 Feb;30(1):3-20. doi: 10.1016/j.dmpk.2014.10.004. Epub 2014 Nov 5.
8
Clinical benefit of sequential use of endocrine therapies for metastatic breast cancer.
Int J Clin Oncol. 2015 Apr;20(2):253-61. doi: 10.1007/s10147-015-0793-8. Epub 2015 Feb 12.
9
Diethylstilboestrol (1 mg) in the management of castration-resistant prostate cancer.
Urol Int. 2015;94(3):307-12. doi: 10.1159/000365198. Epub 2014 Oct 21.
10
Effects of CYP2D6 and UGT2B7 polymorphisms on pharmacokinetics of tamoxifen in Thai breast cancer patients.
Breast Cancer (Dove Med Press). 2013 Aug 22;5:73-8. doi: 10.2147/BCTT.S47172. eCollection 2013.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验